Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis

被引：0
作者：
Shun Takao
Taku Nakashima
Takeshi Masuda
Masashi Namba
Shinjiro Sakamoto
Kakuhiro Yamaguchi
Yasushi Horimasu
Shintaro Miyamoto
Hiroshi Iwamoto
Kazunori Fujitaka
Hironobu Hamada
Shinya Takahashi
Ayumu Nakashima
Noboru Hattori
机构：
[1] Hiroshima University,Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences
[2] Hiroshima University Hospital,Department of Clinical Oncology
[3] Hiroshima University,Department of Physical Analysis and Therapeutic Sciences, Graduate School of Biomedical and Health Sciences
[4] Hiroshima University,Department of Cardiovascular Surgery, Graduate School of Medicine
[5] Hiroshima University,Department of Stem Cell Biology and Medicine, Graduate School of Biomedical and Health Sciences
来源：
Stem Cell Research & Therapy | / 12卷
关键词：
Mesenchymal stromal cells; Serum-free; Bleomycin; Pulmonary fibrosis; Regulatory T cells; Interleukin-6; Transforming growth factor-β;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 303 条
[1]  
Raghu G(2011)An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 788-824
[2]  
Collard HR(2015)An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis an update of the 2011 clinical practice guideline Am J Respirat Crit Care Med 192 e3-19
[3]  
Egan JJ(2016)Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis Pulm Pharmacol Ther 40 95-103
[4]  
Martinez FJ(2011)Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC Cell Commun Signal 9 12-21
[5]  
Behr J(2021)Mesenchymal stem cells: biological characteristics and application in disease therapy Biochimie 185 9-7572
[6]  
Brown KK(2015)Human mesenchymal stem cells—current trends and future prospective Biosci Rep 35 e00191-16
[7]  
Raghu G(2020)MSC based therapies-new perspectives for the injured lung J Clin Med 9 682-169
[8]  
Rochwerg B(2019)Cell-based therapy for idiopathic pulmonary fibrosis Stem cell investigation 6 22-211
[9]  
Zhang Y(2019)Intravenous stem cell dose and changes in quantitative lung fibrosis and DLCO in the AETHER trial: a pilot study Eur Rev Med Pharmacol Sci 23 7568-1366
[10]  
Garcia CA(2020)First-in-human high-cumulative-dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline Stem Cells Transl Med 9 6-627
12345678910